gatifloxacin has been researched along with oxacillin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hiramatsu, K; Hoshi, S; Kikuchi, K; Kinoshita, S; Sasaki, T; Sotozono, C | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Guo, M; Li, YJ; Liu, Y; Piao, HR; Song, MX; Sun, LP; Wu, Y; Zheng, CJ | 1 |
| Hou, SP; Li, YR; Liu, JC; Ma, LX; Piao, HR; Wang, MX; Zheng, CJ | 1 |
| Guo, M; Li, C; Li, YR; Liu, JC; Piao, HR; Sun, LP; Zhang, TY; Zheng, CJ | 1 |
| Chi, KQ; Liu, HY; Piao, HR; Sun, LP; Wei, ZY; Yu, ZK; Zheng, CJ | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; KoĊĦmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Cheng, H; Deng, X; Fu, Z; Liang, Z; Song, M; Wang, S; Wang, Z; Zhou, S | 1 |
| Piao, HR; Sun, LP; Wu, J; Zhang, TY; Zheng, CJ | 1 |
| Du, H; Li, J; Liu, H; Piao, H; Sun, D; Sun, L; Zheng, C | 1 |
| Li, C; Li, YR; Liu, JC; Piao, HR; Wei, ZY; Zhang, W; Zheng, CJ | 1 |
13 other study(ies) available for gatifloxacin and oxacillin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcu
Topics: Administration, Topical; Anti-Bacterial Agents; Drug Administration Routes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Staphylococcus aureus | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.
Topics: Anti-Bacterial Agents; Cell Survival; Drug Resistance, Multiple, Bacterial; Escherichia coli; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolines; Rhodanine; Structure-Activity Relationship | 2013 |
Synthesis and evaluation of the antimicrobial activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one derivatives.
Topics: Anti-Infective Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Infrared; Thiazolidines | 2014 |
Synthesis and biological evaluation of 1,3-diaryl pyrazole derivatives as potential antibacterial and anti-inflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Drug Resistance, Multiple, Bacterial; Furans; Gram-Negative Bacteria; Gram-Positive Cocci; Ibuprofen; Indomethacin; Mice; Pyrazoles | 2015 |
Synthesis and biological evaluation of chalcone derivatives containing aminoguanidine or acylhydrazone moieties.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Cell Line; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Guanidines; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Salmonella typhimurium; Structure-Activity Relationship | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Guanidines; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Semicarbazides; Structure-Activity Relationship | 2019 |
Synthesis of novel dihydrotriazine derivatives bearing 1,3-diaryl pyrazole moieties as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Line; Cell Survival; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2019 |
Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rhodanine; Structure-Activity Relationship; Tryptophan | 2019 |
Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Candida albicans; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Oxacillin; Pyrazoles; Stereoisomerism; Streptococcus mutans; Thiohydantoins | 2016 |